COVID-19 shone a bright light on life sciences with unprecedented results—enterprises getting the new COVID-19 vaccine to market in less than a year. Life sciences enterprises’ ability to create new life-saving therapies, sophisticated medical devices, and other health vehicles continues to be astounding. That progress, however, has been possible because of an ecosystem approach that includes technology and service providers, academia, startups, and various other stakeholders.
In the HFS Horizons: Life Science Service Providers, 2023 study, we evaluated 29 service providers for their ability to address the cost (Horizon 1), experience (Horizon 2), and health outcomes (Horizon 3) for health consumers globally.
Note: All service providers within a Horizon are listed alphabetically.
Source: HFS Research, 2023
To read the rest of the research, click the download button below.
Watch this HFS Videocast on the HFS Horizons: Life Science Service Providers, 2023
Register now for immediate access of HFS' research, data and forward looking trends.
Get Started
If you don't have an account, Register here |
With the exception of our Horizons reports, most of our research is available for free on our website. Sign up for a free account and start realizing the power of insights now.
Our premium subscription gives enterprise clients access to our complete library of proprietary research, direct access to our industry analysts, and other benefits.
Contact us at [email protected] for more information on premium access.
If you are looking for help getting in touch with someone from HFS, please click the chat button to the bottom right of your screen to start a conversation with a member of our team.
